BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15636305)

  • 1. Optimal inhibition of renin angiotensin system to salvage 'at risk' diabetic kidneys--emerging Indian evidence.
    Shah SN; Bansode BR; Kamath SA
    J Assoc Physicians India; 2004 Mar; 52():183-6. PubMed ID: 15636305
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment.
    Andersen NH; Mogensen CE
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):146-52. PubMed ID: 11881115
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin II receptor blockade in diabetic nephropathy.
    Andersen S
    Dan Med Bull; 2004 Aug; 51(3):274-94. PubMed ID: 16009059
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin and its inhibition: a nephrologist point of view.
    Kalra V; Agarwal SK; Wani M
    J Assoc Physicians India; 2002 Oct; 50():1270-80. PubMed ID: 12568213
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin receptors blockers are preferred to angiotensin-converting inhibitors [corrected].
    Feldman L; Weissgarten J
    Isr Med Assoc J; 2004 May; 6(5):299-300. PubMed ID: 15151374
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diabetic nephropathy].
    Metsärinne K
    Duodecim; 2003; 119(24):2445-50. PubMed ID: 14870506
    [No Abstract]   [Full Text] [Related]  

  • 7. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the renin-angiotensin-aldosterone system and renal protection in diabetes mellitus.
    Parving HH
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):30-1. PubMed ID: 11967794
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combined blockade of renin-angiotensine system].
    Robles NR
    Nefrologia; 2003; 23(6):497-503. PubMed ID: 15002784
    [No Abstract]   [Full Text] [Related]  

  • 10. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.
    Raij L
    Am J Hypertens; 2005 Apr; 18(4 Pt 2):95S-99S. PubMed ID: 15837551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
    Hollenberg NK; Epstein M
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
    [No Abstract]   [Full Text] [Related]  

  • 12. [Renoprotection and blockade of the renin-angiotensin system: What shall we believe?].
    Kamper AL; Feldt-Rasmussen B; Strandgaard S
    Ugeskr Laeger; 2006 Apr; 168(15):1563. PubMed ID: 16640988
    [No Abstract]   [Full Text] [Related]  

  • 13. Aldosterone blockade in diabetic nephropathy: relative risks and potential promise.
    Rubin MF; Townsend RR
    J Am Soc Nephrol; 2009 Dec; 20(12):2487-9. PubMed ID: 19875814
    [No Abstract]   [Full Text] [Related]  

  • 14. Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers.
    Berl T
    Nephrol Dial Transplant; 2008 Aug; 23(8):2443-7. PubMed ID: 18467376
    [No Abstract]   [Full Text] [Related]  

  • 15. Treating diabetic nephropathy: unfinished success is not failure.
    Lewis J
    Clin J Am Soc Nephrol; 2007 May; 2(3):407-9. PubMed ID: 17699442
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin receptor blockers do not have an advantage over angiotensin-converting inhibitors [corrected].
    Harman-Boehm I
    Isr Med Assoc J; 2004 May; 6(5):296-8. PubMed ID: 15151373
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological prevention and treatment of diabetic nephropathy].
    Aitio ML
    Duodecim; 1993; 109(6):503-11. PubMed ID: 8062718
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB; Britton ML
    Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of renin angiotensin system blockade on night to day blood pressure ratio in diabetic nephropathy.
    Jacobsen PK; Rossing P; Parving HH
    Nephrol Dial Transplant; 2006 Jul; 21(7):2030-1. PubMed ID: 16449277
    [No Abstract]   [Full Text] [Related]  

  • 20. Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?
    Rossing P; Parving HH; de Zeeuw D
    Nephrol Dial Transplant; 2006 Sep; 21(9):2354-7; discussion 2357-8. PubMed ID: 16928724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.